Search results
Results from the WOW.Com Content Network
Hypoparathyroidism may occur as a complication in up to 8% of anterior neck surgeries with 75% of those resolving by 6 months, and 25% of those having permanent hypoparathyroidism. [5] Kenny–Caffey syndrome; Autoimmune invasion and destruction is the most common non-surgical cause. It can occur as part of autoimmune polyendocrine syndromes.
The most common cause for hypocalcemia is iatrogenic hypoparathyroidism. [2] Other causes include other forms of hypoparathyroidism, vitamin D deficiency, kidney failure, pancreatitis, calcium channel blocker overdose, rhabdomyolysis, tumor lysis syndrome, and medications such as bisphosphonates or denosumab. [1]
It is a genetic developmental disorder [4] with clinical diversity characterized by hypoparathyroidism, sensorineural deafness and renal disease. [5] Sensorineural deafness typically presents in childhood or adolescence. Affected people usually present with hypocalcaemia, tetany, or afebrile convulsions at any age. [1]
APS-1 tends to cause severe symptoms. [4] These are present from early in life, usually around 3.5 years of age. [4] Common symptoms of APS-1 include: Chronic mucocutaneous candidiasis. [4] Hypoparathyroidism. [4] Addison's disease. [4] Ectodermal dystrophy (skin, dental enamel, and nails). APS-1 may also cause: Autoimmune hepatitis. [4 ...
It is estimated that in 10% of cases of drowning as a response to inhalation of water, death occurs due to asphyxia due to laryngospasm without any water in the lungs. [5] It is also a symptom of hypoparathyroidism. [6] It can sometimes occur during sleep, waking up the affected person.
Ascendis Pharma A/S (NASDAQ: ASND) announced topline results from Week 84 of its Phase 2 PaTH Forward Trial of its TransCon PTH candidate hypoparathyroidism (HP). Hypoparathyroidism is a condition ...
This condition causes many diseases related with calcium reabsorption, because the principal function of the parathyroid hormone is to regulate it. Parathyroid surgery could be performed in two different ways: first is a complete parathyroidectomy, and second is the auto transplantation of the removed parathyroid glands.
Recombinant human parathyroid hormone (Natpara) is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in people with hypoparathyroidism. [1] [2] Recombinant human parathyroid hormone (Natpar) is indicated as adjunctive treatment of adults with chronic hypoparathyroidism who cannot be adequately controlled with standard therapy alone.